Blood Pressure-Lowering Effect of Adding Grapefruit Juice to Nifedipine and Terazosin in a Patient with Severe Renovascular Hypertension

Archives of Family Medicine

Volumn 5, Issue 7, 1996, Pages 413-416

  Pisarik, Paul ^a  

^a Cigna   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DRUG DERIVATIVE; NIFEDIPINE; PRAZOSIN; TERAZOSINE;

BEVERAGE; BLOOD PRESSURE; CASE REPORT; CITRUS FRUIT; DRUG EFFECT; FOOD DRUG INTERACTION; HUMAN; MALE; MIDDLE AGED; RENOVASCULAR HYPERTENSION; REVIEW;

ADRENERGIC ALPHA-ANTAGONISTS; BEVERAGES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CITRUS; FOOD-DRUG INTERACTIONS; HUMANS; HYPERTENSION, RENOVASCULAR; MALE; MIDDLE AGED; NIFEDIPINE; PRAZOSIN;

EID: 0030188726     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.5.7.413     Document Type: Article

References (17)

1. Bailey DG, Spence JD, Edgar B, Bayliff CD, Arnold JMO. Ethanol enhances the hemodynamic effects of felodipine. Clin Invest Med. 1989;12:357-362.
2. Edgar B, Bailey DG, Bergstrand R, Johnsson G, Lurje L. Formulation-dependent interaction between felodipine and grapefruit juice. Clin Pharmacol Ther. 1990;47:181. Abstract.
3. Bailey DG, Spence JD, Munoz C, Arnold JMO. Interaction of citrus juices with felodipine and nifedipine. Lancet. 1991;337:268-269.
4. Edgar B, Bailey DG, Bergstrand R, Johnsson G, Regårdh CG. Acute effects of drinking grapefruit juice on the pharmacokinetics and dynamics of felodipine and its potential clinical relevance. Eur J Clin Pharmacol. 1992;42:313-317.
5. Bailey DG, Arnold JMO, Munoz C, Spence JD. Grapefruit juice-felodipine interaction: mechanism, predictability and effect of naringin. Clin Pharmacol Ther. 1993;53:637-642.
6. Bailey DG, Arnold JMO, Tran LT, Ahktar J, Spence JD. Marked effects of both erythromycin and grapefruit juice on felodipine pharmacokinetics. Clin Pharmacol Ther. 1994;55:165. Abstract.
7. Bailey DG, Munoz C, Arnold JMO, Strong HA, Spence JD. Grapefruit juice and naringenin interaction with nitrendipine. Clin Pharmacol Ther. 1992;51:156. Abstract.
8. Bailey DG, Arnold JMO, Strong HA, Munoz C, Spence JD. Effect of grapefruit juice and naringenin on nisoldipine pharmocokinetics. Clin Pharmacol Ther. 1993;54:589-594.
9. Dunselman PHJM, Edgar B. Felopidine clinical pharmacokinetics. Clin Pharmacokinet. 1991;21:418-430.
10. Goa KL, Sorkin EM. Nitrendipine: review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs. 1987;33:123-155.
11. Friedel HA, Sorkin EM. Nisoldipine: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension, and related cardiovascular disorders. Drugs. 1988;36:682-731.
12. Sorkin EM, Clissold SP, Brogden RN. Nifedipine: review of its pharmocodynamic and pharmcokinetic properties and efficacy in ischemic heart disease, hypertension and related cardiovascular disorders. Drugs. 1985;30:182-274.
13. Miniscalco A, Lundahl J, Regårdh CG, Edgar B, Eriksson UG. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther. 1992;261:1195-1199.
14. Rashid J, McKinstry C, Renwick AG, et al. Quercetin, an in vitro inhibitor of CYP3A, does not contribute to the interaction between nifedipine and grapefruit juice. Br J Clin Pharmacol. 1993;36:460-463.
15. Kühnau J. The flavonoids: a class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet. 1976;24:117-191.
16. Hertog MG, Hollman PC, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in the Netherlands. Nutr Cancer. 1993;20:21-29.
17. Bailey DG, Arnold JMO, Spence JD. Grapefruit juice and drugs: how significant is the interaction? Clin Pharmacokinet. 1994;26:91-98.